ocation and vein for the treatment of Sciatica disorder by blood letting.
Not Applicable
- Conditions
- Health Condition 1: G570- Lesion of sciatic nerve
- Registration Number
- CTRI/2023/11/060124
- Lead Sponsor
- Dr Samadhan Madhukar Patil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patients of both genders.
2) Patients age in between 20-60 years.
3) Diagnosed cases of Gridhrasi who have been advised to Siravedha at Antara kandara Gulpha.
Exclusion Criteria
1) Patients age below 20 years & above 60 years
2) Pregnant and lactating mother
3) K/C/O - Uncontrolled diabetes mellitus, hypertension, tuberculosis of spine and hip joint, malignancy of spine or other organs, Avascular necrosis & other bleeding disorders
4) Fracture related to spine and lower limb
5) Cardiac diseases (ischemic heart disease, coronary artery disease, myocardial infarction etc.)
6) Patient having any major surgical and systemic illness.
7) Patient not willing to participate in the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The structure for Siravedha at Antara Kandara Gulpha in Gridhrasi patients will be confirmed by this study <br/ ><br>Timepoint: 1 year
- Secondary Outcome Measures
Name Time Method 1. Study of Antara Kandara Gulpha Sira. <br/ ><br>2. Establishment of relation between Antara Kandara Gulpha Sira & Great saphenous vein. <br/ ><br>3. Identification of vein that is selected for Siravedh in Gridhrasi patients. <br/ ><br>4. Measuring flask reading will be observed for quantity of bloodletting. <br/ ><br>5. Pulse & blood pressure will be taken on CRF according to OPD or IPD case paper. <br/ ><br>Timepoint: 24-28 weeks